We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cheaper Genome Mapping on the Way

By Biotechdaily staff writers
Posted on 23 Aug 2005
Researchers have used off-the-shelf instruments and chemical reagents to create a DNA sequencing method that may dramatically reduce the cost of genome mapping.

Investigators at Harvard Medical School (Boston, MA, USA) have converted a commonly available, inexpensive epifluorescence microscope into an automatic non-electrophoretic DNA sequencing instrument. More...
The microscope with attached digital camera and associated computers was used to retrieve data that were generated by a cell-free, mate-paired library that provided single DNA molecules that were amplified in parallel to one-micrometer beads by emulsion PCR (polymerase chain reaction). Millions of gene fragments were immobilized in a polyacrylamide gel and subjected to automated cycles of sequencing and four-color imaging. Fluorescing DNA nucleotides were detected by the microscope's camera, and the results were sent to computers that reinterpreted the data as a linear sequence of base pairs.

Today it costs more than U.S.$20 million dollars to map a complete human genome. Using the new method, as described in the August 4, 2005, online edition of Science, the price can be reduced to about $2.2 million. The authors believe that in the near future this cost can be reduced to as little at $1,000, which would bring genome mapping into the realm of clinical diagnostics. Senior author Dr. George Church, professor of genetics at Harvard Medical School, said, "The cost of $1,000 for a human genome should allow prioritization of detailed diagnostics and therapeutics, as is already happening with cancer.”




Related Links:
Harvard Medical School

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Repetitive Pipette
VWR® Stepper Pro
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.